These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 7105621

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Interactions of dihydralazine with furosemide in hypertonic patients.
    Siegmund W, Kairies M, Franke G, Donner I, Biebler KE.
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):148-51. PubMed ID: 3557742
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure.
    Chaturvedi PR, O'Donnell JP, Nicholas JM, Shoenthal DR, Waters DH, Gwilt PR.
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):123-8. PubMed ID: 3557737
    [Abstract] [Full Text] [Related]

  • 6. Distribution, elimination and effect of furosemide in normal subjects and in patients with heart failure.
    Andreasen F, Mikkelsen E.
    Eur J Clin Pharmacol; 1977 Aug 17; 12(1):15-22. PubMed ID: 902673
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Determinants of systemic availability of oral hydralazine in heart failure.
    Crawford MH, Ludden TM, Kennedy GT.
    Clin Pharmacol Ther; 1985 Nov 17; 38(5):538-43. PubMed ID: 4053489
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of oral hydralazine in chronic heart failure.
    Hanson A, Johansson BW, Wernersson B, Wåhlander LA.
    Eur J Clin Pharmacol; 1983 Nov 17; 25(4):467-73. PubMed ID: 6653641
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Plasma and urinary kinetics of furosemide in newborn infants.
    Tuck S, Morselli P, Broquaire M, Vert P.
    J Pediatr; 1983 Sep 17; 103(3):481-5. PubMed ID: 6886918
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of probenecid on furosemide kinetics and natriuresis in man.
    Honari J, Blair AD, Cutler RE.
    Clin Pharmacol Ther; 1977 Oct 17; 22(4):395-401. PubMed ID: 902452
    [Abstract] [Full Text] [Related]

  • 15. Effect of furosemide and trimethazidine on kinetic behavior and hypotensive effect of hydralazine in rats.
    Ogiso T, Iwaki M, Ohtori A.
    J Pharmacobiodyn; 1986 Jan 17; 9(1):1-11. PubMed ID: 3712206
    [Abstract] [Full Text] [Related]

  • 16. Extracardial effects of oral ibopamine versus furosemide in patients with mild or moderate heart failure. A double-blind, randomized trial.
    Wehling M, Zimmermann J, Theisen K.
    Cardiology; 1990 Jan 17; 77 Suppl 5():81-8. PubMed ID: 2279257
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Studies on hydralazine. II. Elimination rate and steady-state concentration in patients with impaired renal function.
    Talseth T.
    Eur J Clin Pharmacol; 1976 Sep 30; 10(5):311-7. PubMed ID: 976304
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.